[Treatment of choreic syndromes with sodium dipropylacetate].
The therapeutic activity of natrium dipropilaceticum in two cases of Huntington chorea and in one case of vascular chorea, has been valued. DPA has putted into evidence a scarce activity in Huntington chorea cases; on the contrary it has showed a high activity for the vascular chorea ones.
D002561:Cerebrovascular Disorders / Q000150:complications; D002819:Chorea / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010919:Placebos; D014631:Valerates / Q000627:therapeutic use*; D014635:Valproic Acid / Q000627:therapeutic use*
D010919:Placebos; D014631:Valerates; D014635:Valproic Acid
II trattamento delle sindromi coreiche con dipropilacetato di sodio